SEC Info - NowRx, Inc. - ‘1-U’ for 10/1/21

SEC Info℠

Home

Help

Please Sign In

NowRx, Inc. – ‘1-U’ for 10/1/21

On: Tuesday, 10/12/21, at 6:09am ET · For: 10/1/21 · Accession #: 1104659-21-124903

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/12/21  NowRx, Inc.                       1-U:9      10/01/21    2:95K                                    Toppan Merrill/FA

Current Report — Form 1-U — Regulation A

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 1-U         Current Report                                      HTML     10K 
 2: EX1U-2A CHARTER  Exhibit 2.1                                    HTML     63K

‘1-U’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 1-U

Current Report Pursuant to Regulation A

Date of Report: October 1, 2021

(Date of earliest event reported)

NowRx, Inc.

(Exact name of issuer as specified in its charter)

Delaware		47-4054162
(State or other incorporation)		(I.R.S. Employer Identification No.)

2224 Old Middlefield Way

Mountain View, CA 94043

(Full mailing address of principal executive offices)

(650) 386-5761

(Issuer’s telephone number, including area code)

Series A Preferred Stock

Series B Preferred Stock

(Title of each class of securities issued pursuant to Regulation A)

Item 9.

Other Events.

Filing of Third Amended and Restated Certificate of Incorporation

On October 1, 2021, NowRx, Inc. (the “Company”) filed with the State of Delaware its Third Amended and Restated Certificate of Incorporation (the “Certificate”). The Certificate is filed as Exhibit 2.1 to this Current Report on Form 1-U.

SIGNATURES

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NowRx, Inc.

	By:	/s/ *Cary Breese*
	Name:	Cary Breese
	Title:	Chief Executive Officer

	Date:	October 12, 2021

Exhibit Index

Exhibit No.		Description

2.1		Third Amended and Restated Certificate of Incorporation.

Dates Referenced Herein

This ‘1-U’ Filing	Date	Other Filings

Filed on:	10/12/21	None on these Dates
For Period end:	10/1/21
		List all Filings

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/28/22  NowRx, Inc.                       1-SA        6/30/22    3:946K                                   Toppan Merrill/FA
 5/02/22  NowRx, Inc.                       1-K        12/31/21    3:1.4M                                   Toppan Merrill/FA

↑Top

Filing Submission 0001104659-21-124903 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)